Unicycive Therapeutics clinical trials we track

Check company identity source

Phase 2 1 trial

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-06-29DayOxylanthanum CarbonateUnicycive Therapeutics, Inc · UNCYFDA complete response letterComplete response letterNot specifiedOpen original source
Read source excerpt

{"application_number": ["NDA 218607"], "letter_date": "06/29/2026", "letter_type": "COMPLETE RESPONSE", "company_name": "Unicycive Therapeutics Inc.", "file_name": "CRL_NDA218607_20260629.pdf"}

First seen: 26 Sep 2026 · Evidence last checked: 26 Sep 2026

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.